Elliot McVeigh

About

Elliot R. McVeigh, PhD, is the Lab Director of the Cardiovascular Imaging Lab (McVeigh Lab) at the University of California, San Diego. Before joining UCSD, he was the chair of the Department of Biomedical Engineering at Johns Hopkins University, where he founded the Medical Imaging Laboratory. In 1999, McVeigh collaborated with the Laboratory of Cardiac Energetics at the National Institutes of Health to develop a research program focused on cardiovascular interventional MRI. He joined the Johns Hopkins faculty in 1988 immediately after earning his Ph.D. in medical biophysics from the University of Toronto, where he also completed a bachelor's degree in physics in 1984. McVeigh's work integrates bioengineering, medical imaging, and clinical collaboration, particularly with specialists in Radiology, General Cardiology, Interventional Cardiology, Electrophysiology, and heart failure, to form comprehensive research teams aimed at advancing cardiovascular imaging and intervention.

Research topics

• Internal medicine
• Computer Science
• Medicine
• Mathematics
• Cardiology
• Engineering
• Demography
• Optics
• Anatomy
• Biology

Selected publications

• Demonstration of Patient-Specific Simulations to Assess Left Atrial Appendage Thrombogenesis Risk

  Frontiers in Physiology · 2021 · 104 citations

  Atrial fibrillation (AF) alters left atrial (LA) hemodynamics, which can lead to thrombosis in the left atrial appendage (LAA), systemic embolism and stroke. A personalized risk-stratification of AF patients for stroke would permit improved balancing of preventive anticoagulation therapies against bleeding risk. We investigated how LA anatomy and function impact LA and LAA hemodynamics, and explored whether patient-specific analysis by computational fluid dynamics (CFD) can predict the risk of L…

  DOI

• Constructing a Human Atrial Fibre Atlas

  Annals of Biomedical Engineering · 2020 · 79 citations

  Atrial anisotropy affects electrical propagation patterns, anchor locations of atrial reentrant drivers, and atrial mechanics. However, patient-specific atrial fibre fields and anisotropy measurements are not currently available, and consequently assigning fibre fields to atrial models is challenging. We aimed to construct an atrial fibre atlas from a high-resolution DTMRI dataset that optimally reproduces electrophysiology simulation predictions corresponding to patient-specific fibre fields, a…

  DOI

• Targeted Coronary Artery Calcium Screening in High-Risk Younger Individuals Using Consumer Genetic Screening Results

  JACC. Cardiovascular imaging · 2021 · 29 citations

  Senior authorCorresponding
  DOI

• Impact of technical, patient-related and measurement variables on serial Hounsfield unit–based quantitative coronary plaque analysis in computed tomography: time for a new chapter

  European Heart Journal - Imaging Methods and Practice · 2025-01-01 · 5 citations

  reviewOpen access

  This review article explores the challenges and controversies involved in accurately identifying and reliably quantifying coronary plaque over time through coronary computed tomography angiography (CCTA), particularly focusing on lipid-rich, low-attenuation plaques. It highlights significant variability in lipid-rich plaque measurements across studies, questioning their reliability for tracking biological plaque transformation in clinical practice. To address this issue, the review article propo…

  PublisherDOI

• Hemodynamics affects factor XI/XII anticoagulation efficacy in patient-derived left atrial models

  Computer Methods and Programs in Biomedicine · 2025-04-21 · 4 citations

  articleOpen access

  BACKGROUND AND OBJECTIVE: Atrial fibrillation (AF) is a common arrhythmia that disrupts blood circulation in the left atrium (LA), causing stasis in the left atrial appendage (LAA) and increasing thromboembolic risk. In patients at sufficiently high risk, anticoagulation is indicated. This benefit may be counterbalanced by an increased risk of bleeding. Novel anticoagulants under development, such as factor XI/XII inhibitors, may be associated with a lower bleeding risk. However, their efficacy…

  PublisherDOI

Recent grants

• True 4DCT for Quantifying LV Dyssynchrony and Function for Targeting LV Lead Location in CRT

  NIH · $2.4M · 2019–2023

• NIH Grant R01HL045683

  NIH · $1.6M · 2003

• NIH Grant R29HL045683

  NIH · $581k · 1997

Frequent coauthors

• Michael A. Guttman

  Johns Hopkins Medicine

  169 shared

• Robert J. Lederman

  166 shared

• Daniel A. Herzka

  152 shared

• Cengizhan Öztürk

  Boğaziçi University

  141 shared

• Hiroshi Ashikaga

  Johns Hopkins Medicine

  127 shared

• Peter Kellman

  National Heart Lung and Blood Institute

  106 shared

• Ergin Atalar

  Bilkent University

  91 shared

• J. Andrew Derbyshire

  81 shared

Labs

• Cardiovascular Imaging Lab (McVeigh Lab)PI

  Investigators and students in CViL come from diverse backgrounds. Bioengineers, Electrical, Mechanical engineers and Physicists form the technical core of the team.

Similar researchers at University of California, San Diego

• Rob Knighth-297
• Ludmil Alexandrovh-102
• Andrew McCullochh-88